Search

Search Results

• 2026 iCARDIO Alliance Global Implementation Guidelines on Heart Failure

  Vijay Chopra, William T. Abraham, Offer Amir, Stefan D. Anker, John J. Atherton, Fernando Bacal, Ralph Stephan von Bardeleben , Dulce Brito, Lucrecia Maria Burgos, Javed Butler, Maria Rosa Costanzo, Albertino Damasceno, Justin A. Ezekowitz, Ishaque Hameed, Sivadasanpillai Harikrishnan, Anuradha Lala, Ileana L. Piña, Clara Saldarriaga, David Sim, John R. Teerlink, Nqoba Tsabedze, Hiroyuki Tsutsui, Jing Yu, Yuhui Zhang, Mohammad Zubaid, Nikhil Balankhe, John G.F. Cleland, Gemma Figtree, Gerasimos Filippatos, Marat Fudim, Habib Gamra, Juan Esteban Gomez-Mesa, Martha Gulati, James L. Januzzi, Marvin A. Konstam, JoAnn Lindenfeld, Robert J. Mentz, Rhonda Monroe, Elijah Ogola, Fausto J. Pinto, Girish C. Rajadhyaksha, Carlos E. Ramos, Giuseppe Rosano, Victor Rossel, Naoki Sato, P. Christian Schulze, Andrew Sindone, Kadhim Sulaiman, Muthiah Vaduganathan, Harriette G.C. Van Spall, Dirk J. van Veldhuisen, Stephan von Haehling, Tzung-Dau Wang, Pepe Zamorano, Michael Böhm, Andrew J.S. Coats, Shelley Zieroth

  2026-08-24

  https://doi.org/10.4081/cardio.2026.117

  2971

  PDF: 1611

  APPENDIX: 145

  HTML: 28

• What is new and what has changed in the 2026 Global Heart Failure Implementation Guidelines and why

  Vijay Chopra, William T. Abraham, Offer Amir, Stefan D. Anker, John J. Atherton, Fernando Bacal, Ralph Stephan von Bardeleben, Dulce Brito, Lucrecia Maria Burgos, Javed Butler, Maria Rosa Costanzo, Albertino Damasceno, Justin A. Ezekowitz, Ishaque Hameed, Sivadasanpillai Harikrishnan, Anuradha Lala, Ileana L. Piña, Clara Saldarriaga, David Sim , John R. Teerlink, Nqoba Tsabedze, Hiroyuki Tsutsui, Jing Yu, Yuhui Zhang, Mohammad Zubaid, Nikhil Balankhe, John G.F. Cleland, Gemma Figtree, Gerasimos Filippatos, Marat Fudim, Habib Gamra, Juan Esteban Gomez-Mesa, Martha Gulati, James L. Januzzi, Marvin A. Konstam, JoAnn Lindenfeld, Robert J. Mentz, Rhonda Monroe, Elijah Ogola, Fausto J. Pinto, Girish C. Rajadhyaksha, Carlos E. Ramos, Giuseppe Rosano, Victor Rossel, Naoki Sato, P. Christian Schulze, Andrew Sindone, Kadhim Sulaiman, Muthiah Vaduganathan, Harriette G.C. Van Spall, Dirk J. van Veldhuisen, Stephan von Haehling, Tzung-Dau Wang, Pepe Zamorano, Michael Böhm, Andrew J.S. Coats, Shelley Zieroth

  2026-08-24

  https://doi.org/10.4081/cardio.2026.118

  913

  PDF: 612

  APPENDIX: 121

  HTML: 31
• 

  The effect of sauna on cardiac and skeletal muscle function in patients with HFpEF (SAUNA-HFpEF): rationale and design

  Tarek Bekfani, Kris G. Vargas, Flor Gomez, Alexander Schmeisser, Ruediger C. Braun-Dullaeus

  2025-06-30

  https://doi.org/10.4081/cardio.2025.67

  3304

  PDF: 727

  HTML: 170

• Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients

  Javed Butler, Sanjiv J. Shah, Melissa Magwire, Carlos Campos, Muhammad Shariq Usman, Anthony Hoovler, Anup Sabharwal, Barry A. Borlaug

  2024-06-28

  https://doi.org/10.4081/cardio.2024.38

  2644

  PDF: 1288

  SUPPLEMENTARY MATERIAL: 413

  GRAPHICAL ABSTRACT: 345

  HTML: 228

• Mineralocorticoid receptor antagonists in heart failure with preserved (and mildly reduced) ejection fraction: a comparative review of spironolactone and finerenone

  Hafsa Azam, Syed Sarmad Javaid, Mahir Karakas

  2026-07-06

  https://doi.org/10.4081/cardio.2026.110

  423

  PDF: 234

  HTML: 36

• Effect of metformin and empagliflozin on myocardial function in insulin-resistant patients with heart failure: rationale and design of the METRIS-HF-DZHK18 Trial

  Wolfram Doehner, Tim Friede, Frank Edelmann, Ulf Landmesser, Sebastian Winkler, Burkert Pieske, Fabian Knebel, Sebastian Kelle, Diethelm Tschöpe, Antje Meyer, Nadja Jauert, Marius Placzek, Jeanette Schulz-Menger, Stephan von Haehling, Stefan D. Anker

  2025-12-31

  https://doi.org/10.4081/cardio.2025.89

  592

  PDF: 511

  Appendix: 97

  HTML: 24

• Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-07-16

  https://doi.org/10.4081/cardio.2025.76

  1083

  PDF: 439

  Supplementary: 240

  Appendix: 263

  HTML: 78

• iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease 2026

  Fausto J. Pinto, Martha Gulati, Daniel Caldeira, Clara K. Chow, Luis Henrique Wolff Gowdak, Dipti Itchhaporia, Abdulla Shehab, Gurpreet Singh Wander, Beth L. Abramson, Takashi Akasaka, Giuseppe Ambrosio, Alexandra Arias-Mendoza, Otavio Berwanger, Anastase Dzudie, Evangelos Giannitsis, Rania Hammami, Neil Johnson, Vijay Kunadian, Renato D. Lopes, Athanasios Manolis, Girish Mathur, Giuseppe M.C. Rosano, Ana Salvati, Gregg W. Stone, Jean-Claude Tardif, Ping Xie, Jian Zhang, Mohammad Zubaid, William T. Abraham, Wael Abuzeid, Rasha AlBawardy, Thomas Alexander , Stefan D. Anker , John J. Atherton, Andrea Baer, Rakesh Bhadade, William E. Boden, Gabriela Borrayo Sanchez, Javed Butler, Edina Cenko, Edith H. Chavez , Vijay Chopra, Andrew J.S. Coats, Marcelo Di Carli, Jianzeng Dong, Jan Fedacko, Gerasimos Filippatos, Abdoul Kane, Muhammad Shahzeb Khan, Pablos Lamelas, Michael Lee, Haroldo Lopez, Angela H.E.M. Maas, Mpiko Ntsekhe, Pat O’Donnell, Gian Piero Perna, Miguel Quintana, Bagirath Raghuraman, Ruchit Shah, Vladimir Ullauri, Sarah Zaman, Jose Luis Zamorano, Yuhui Zhang, Sheng-hua Zhou, Shelley Zieroth, Rod Zimmermann, Habib Gamra, Maria Ines Sosa Liprandi, Juan-Carlos Kaski

  2026-08-24

  https://doi.org/10.4081/cardio.2026.112

  1885

  PDF: 1625

  APPENDIX: 198

  HTML: 40

• Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trial

  Stephan von Haehling, Wolfram Doehner, Ruben Evertz, Tania Garfias-Veitl, Monika Diek, Mahir Karakas, Ralf Birkemeyer, Gerasimos Fillippatos, Piotr Ponikowski, Michael Böhm, Tim Friede, Stefan D. Anker

  2023-12-27

  https://doi.org/10.4081/cardio.2023.15

  3088

  pdf: 949

  HTML: 79

• The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis

  Muhammad Shariq Usman, Arsalan Hamid, Shurjeel Uddin Qazi, Mikhail N. Kosiborod, Deepak L. Bhatt, Muhammad Shahzeb Khan, Muthiah Vaduganathan, Javed Butler

  2024-06-28

  https://doi.org/10.4081/cardio.2024.35

  3916

  PDF: 937

  Conflict of interest: 405

  SUPPLEMENTARY MATERIAL: 361

  HTML: 142

• Beyond trial neutrality: treatment discontinuation and the hidden signal in SPIRIT-HF trial

  Viana Copeland, Andrew J.S. Coats

  2026-03-31

  https://doi.org/10.4081/cardio.2026.100

  1586

  PDF: 472

  HTML: 284

• The association of iron deficiency with right ventricular dysfunction in Africans with heart failure

  Adeseye A. Akintunde, Sope T. Orugun

  2024-12-30

  https://doi.org/10.4081/cardio.2024.53

  3035

  PDF: 518

  Appendix B: 574

  Appendix A: 396

  HTML: 19

• Exercise capacity, iron deficiency and depressive symptoms in patients with asymptomatic chronic systolic heart failure

  Sven Christopher Aland, Christoph Gertler, Hannah Leonie Bräunig, Timo Schröder, Frank Edelmann, Rolf Wachter, Christoph Herrmann-Lingen, Gerd Hasenfuß, Anja Sandek

  2024-06-28

  https://doi.org/10.4081/cardio.2024.39

  2072

  PDF: 704

  HTML: 31

• SMART-HF: structured management approach to remote treatment of heart failure. Guiding best practices

  Marc Atzenhoefer, Tamar Atzenhoefer, Hussain Boxwala, Brooke Nelson, Michelle Staudacher, Fahad Iqbal

  2026-09-11

  https://doi.org/10.4081/cardio.2026.116

  125

  PDF: 149

  HTML: 7

• Hypertension-related heart failure mortality among older adults in the United States: a nationwide analysis of demographic and regional trends

  Muhammad Muneeb Ur Rehman, Muhammad Sameer Arshad, Muhammad Abdul Tawab, Rahael Javaid, Sunil Modi, Marat Fudim

  2026-03-31

  https://doi.org/10.4081/cardio.2026.97

  1500

  PDF: 490

  SUPPLEMENTARY FILES: 302

  HTML: 182

• Using multiple primary endpoints in clinical trials with a focus on heart failure

  Stefan D. Anker, Javed Butler, Khawaja M. Talha, Tim Friede

  2024-06-28

  https://doi.org/10.4081/cardio.2024.33

  6719

  PDF: 1040

  HTML: 464

• Beyond oral and intravenous diuretics: intranasal bumetanide for heart failure decongestion

  Hafsa Azam, Markus S. Anker, Ovidiu Chioncel, Muhammad Shahzeb Khan, Javed Butler

  2026-07-10

  https://doi.org/10.4081/cardio.2026.109

  406

  PDF: 201

  HTML: 18

• SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials

  Tariq Jamal Siddiqi, Javed Butler, Andrew J.S. Coats, Subodh Verma, Tim Friede, Gerasimos Filippatos, Stefan D. Anker

  2023-11-23

  https://doi.org/10.4081/cardio.2023.2

  1644

  pdf: 459

  Supplementary Material: 116

  HTML: 257

• Aldosterone synthase inhibitors in cardio-renal diseases: a state-of-the-art review

  Muhammad Hamza Dawood, Muhammad Shahzeb Khan, Ahmed Mustafa Rashid, Wilhelm Haverkamp

  2025-12-31

  https://doi.org/10.4081/cardio.2025.91

  1151

  PDF: 784

  HTML: 157